State Of Wisconsin Investment Board Syros Pharmaceuticals, Inc. Transaction History

State Of Wisconsin Investment Board

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$3.26 - $4.66 $194,775 - $278,421	-59,747 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$5.01 - $7.48 $118,737 - $177,276	-23,700 Reduced 28.4%	59,747 $326,000
Q1 2021 May 17, 2021	SELL	$7.19 - $14.95 $45,297 - $94,185	-6,300 Reduced 7.02%	83,447 $624,000
Q4 2020 Feb 03, 2021	SELL	$6.66 - $14.66 $54,612 - $120,212	-8,200 Reduced 8.37%	89,747 $974,000
Q3 2020 Nov 16, 2020	BUY	$8.69 - $14.47 $386,244 - $643,148	44,447 Added 83.08%	97,947 $866,000
Q2 2020 Aug 12, 2020	SELL	$5.21 - $11.03 $68,772 - $145,596	-13,200 Reduced 19.79%	53,500 $570,000
Q1 2020 May 06, 2020	BUY	$4.46 - $9.2 $65,562 - $135,240	14,700 Added 28.27%	66,700 $396,000
Q3 2019 Nov 12, 2019	BUY	$7.14 - $11.65 $119,952 - $195,720	16,800 Added 47.73%	52,000 $540,000
Q2 2019 Aug 14, 2019	BUY	$5.5 - $9.75 $4,400 - $7,800	800 Added 2.33%	35,200 $326,000
Q1 2019 May 13, 2019	BUY	$5.51 - $9.59 $42,978 - $74,802	7,800 Added 29.32%	34,400 $314,000
Q4 2018 Feb 11, 2019	BUY	$5.55 - $11.34 $4,995 - $10,206	900 Added 3.5%	26,600 $148,000
Q3 2018 Nov 14, 2018	BUY	$9.74 - $12.92 $250,318 - $332,044	25,700 New	25,700 $306,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.